APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Malarial Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Malarial Drug Market Outlook and Growth Opportunities 2026

20 December 2025193 pages

Choose your research edition.

Industry ResearchAnti-Malarial Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Malarial Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Anti-Malarial Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Malarial Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Malarial Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anti-Malarial Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Malarial Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Malarial Drug market include Alvizia, F. Hoffmann-La Roche, Ipca, Ranbaxy, Zydus Cadila, Bayer, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Malarial Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Malarial Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Malarial Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Malarial Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Malarial Drug Segment by Company

Alvizia

F. Hoffmann-La Roche

Ipca

Ranbaxy

Zydus Cadila

Bayer

GlaxoSmithKline

Pfizer

Merck

Novartis

Anti-Malarial Drug Segment by Type

Plasmodium Falciparum

Plasmodium Vivax

Plasmodium Ovale

Plasmodium Malariae

Anti-Malarial Drug Segment by Application

E-Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Anti-Malarial Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anti-Malarial Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-Malarial Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Malarial Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Malarial Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Malarial Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Malarial Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Malarial Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Malarial Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Malarial Drug industry.

Chapter 3: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-Malarial Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-Malarial Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Malarial Drug Industry Trends Table 2. Anti-Malarial Drug Industry Drivers Table 3. Anti-Malarial Drug Industry Opportunities and Challenges Table 4. Anti-Malarial Drug Industry Restraints Table 5. Global Anti-Malarial Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Malarial Drug Revenue Share by Company (2021-2026) Table 7. Global Anti-Malarial Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anti-Malarial Drug Sales Volume Share by Company (2021-2026) Table 9. Global Anti-Malarial Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-Malarial Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-Malarial Drug Key Company Manufacturing Base & Headquarters Table 12. Global Anti-Malarial Drug Company, Product Type & Application Table 13. Global Anti-Malarial Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plasmodium Falciparum Table 18. Significant Companies of Plasmodium Vivax Table 19. Significant Companies of Plasmodium Ovale Table 20. Significant Companies of Plasmodium Malariae Table 21. Global Anti-Malarial Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Anti-Malarial Drug Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Anti-Malarial Drug Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Anti-Malarial Drug Sales Volume Share by Type (2021-2026) Table 25. Global Anti-Malarial Drug Sales Volume Share by Type (2027-2032) Table 26. Global Anti-Malarial Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Anti-Malarial Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Anti-Malarial Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Anti-Malarial Drug Sales Value Share by Type (2021-2026) Table 30. Global Anti-Malarial Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of E-Commerce Table 32. Significant Companies of Retail Pharmacy Table 33. Significant Companies of Hospital Pharmacy Table 34. Significant Companies of Others Table 35. Global Anti-Malarial Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Anti-Malarial Drug Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Anti-Malarial Drug Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Anti-Malarial Drug Sales Volume Share by Application (2021-2026) Table 39. Global Anti-Malarial Drug Sales Volume Share by Application (2027-2032) Table 40. Global Anti-Malarial Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Anti-Malarial Drug Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Anti-Malarial Drug Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Anti-Malarial Drug Sales Value Share by Application (2021-2026) Table 44. Global Anti-Malarial Drug Sales Value Share by Application (2027-2032) Table 45. Global Anti-Malarial Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Anti-Malarial Drug Sales by Region (2021-2026) & (K Units) Table 47. Global Anti-Malarial Drug Sales Market Share by Region (2021-2026) Table 48. Global Anti-Malarial Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Anti-Malarial Drug Sales Market Share by Region (2027-2032) Table 50. Global Anti-Malarial Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Anti-Malarial Drug Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Anti-Malarial Drug Sales Value Share by Region (2021-2026) Table 53. Global Anti-Malarial Drug Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Anti-Malarial Drug Sales Value Share by Region (2027-2032) Table 55. Global Anti-Malarial Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Anti-Malarial Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Anti-Malarial Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 60. Global Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 61. Global Anti-Malarial Drug Sales by Country (2027-2032) & (K Units) Table 62. Global Anti-Malarial Drug Sales Market Share by Country (2027-2032) Table 63. Global Anti-Malarial Drug Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Anti-Malarial Drug Sales Value Market Share by Country (2021-2026) Table 65. Global Anti-Malarial Drug Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Anti-Malarial Drug Sales Value Market Share by Country (2027-2032) Table 67. Alvizia Company Information Table 68. Alvizia Business Overview Table 69. Alvizia Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Alvizia Anti-Malarial Drug Product Portfolio Table 71. Alvizia Recent Development Table 72. F. Hoffmann-La Roche Company Information Table 73. F. Hoffmann-La Roche Business Overview Table 74. F. Hoffmann-La Roche Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio Table 76. F. Hoffmann-La Roche Recent Development Table 77. Ipca Company Information Table 78. Ipca Business Overview Table 79. Ipca Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Ipca Anti-Malarial Drug Product Portfolio Table 81. Ipca Recent Development Table 82. Ranbaxy Company Information Table 83. Ranbaxy Business Overview Table 84. Ranbaxy Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ranbaxy Anti-Malarial Drug Product Portfolio Table 86. Ranbaxy Recent Development Table 87. Zydus Cadila Company Information Table 88. Zydus Cadila Business Overview Table 89. Zydus Cadila Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Zydus Cadila Anti-Malarial Drug Product Portfolio Table 91. Zydus Cadila Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bayer Anti-Malarial Drug Product Portfolio Table 96. Bayer Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Anti-Malarial Drug Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Anti-Malarial Drug Product Portfolio Table 106. Pfizer Recent Development Table 107. Merck Company Information Table 108. Merck Business Overview Table 109. Merck Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Merck Anti-Malarial Drug Product Portfolio Table 111. Merck Recent Development Table 112. Novartis Company Information Table 113. Novartis Business Overview Table 114. Novartis Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Novartis Anti-Malarial Drug Product Portfolio Table 116. Novartis Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Anti-Malarial Drug Distributors List Table 120. Anti-Malarial Drug Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Anti-Malarial Drug Product Image Figure 2. Global Anti-Malarial Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-Malarial Drug Sales (2021-2032) & (K Units) Figure 5. Global Anti-Malarial Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-Malarial Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plasmodium Falciparum Image Figure 10. Plasmodium Vivax Image Figure 11. Plasmodium Ovale Image Figure 12. Plasmodium Malariae Image Figure 13. Global Anti-Malarial Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-Malarial Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-Malarial Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Anti-Malarial Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Anti-Malarial Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Anti-Malarial Drug Sales Value Share by Type (2021-2032) Figure 19. E-Commerce Image Figure 20. Retail Pharmacy Image Figure 21. Hospital Pharmacy Image Figure 22. Others Image Figure 23. Global Anti-Malarial Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Anti-Malarial Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Anti-Malarial Drug Sales Volume Share by Application (2021-2032) Figure 26. Global Anti-Malarial Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Anti-Malarial Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Anti-Malarial Drug Sales Value Share by Application (2021-2032) Figure 29. Global Anti-Malarial Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Anti-Malarial Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Anti-Malarial Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Anti-Malarial Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 34. North America Anti-Malarial Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Anti-Malarial Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Anti-Malarial Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 40. South America Anti-Malarial Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Anti-Malarial Drug Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Anti-Malarial Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Anti-Malarial Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Anti-Malarial Drug Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Anti-Malarial Drug Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Plasmodium Ovale
  • Plasmodium Malariae
Applications
  • E-Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Alvizia
  • F. Hoffmann-La Roche
  • Ipca
  • Ranbaxy
  • Zydus Cadila
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Malarial Drug Sales Value (2021-2032)
  4. 1.2.2 Global Anti-Malarial Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-Malarial Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-Malarial Drug Market Dynamics
  1. 2.1 Anti-Malarial Drug Industry Trends
  2. 2.2 Anti-Malarial Drug Industry Drivers
  3. 2.3 Anti-Malarial Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Malarial Drug Industry Restraints
3 Anti-Malarial Drug Market by Company
  1. 3.1 Global Anti-Malarial Drug Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Malarial Drug Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Malarial Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-Malarial Drug Average Price by Company (2021-2026)
  5. 3.5 Global Anti-Malarial Drug Company Ranking (2024-2026)
  6. 3.6 Global Anti-Malarial Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-Malarial Drug Company Product Type and Application
  8. 3.8 Global Anti-Malarial Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-Malarial Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-Malarial Drug Market by Type
  1. 4.1 Anti-Malarial Drug Type Introduction
  2. 4.1.1 Plasmodium Falciparum
  3. 4.1.2 Plasmodium Vivax
  4. 4.1.3 Plasmodium Ovale
  5. 4.1.4 Plasmodium Malariae
  6. 4.2 Global Anti-Malarial Drug Sales Volume by Type
  7. 4.2.1 Global Anti-Malarial Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-Malarial Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Anti-Malarial Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Anti-Malarial Drug Sales Value by Type
  11. 4.3.1 Global Anti-Malarial Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-Malarial Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Anti-Malarial Drug Sales Value Share by Type (2021-2032)
5 Anti-Malarial Drug Market by Application
  1. 5.1 Anti-Malarial Drug Application Introduction
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Anti-Malarial Drug Sales Volume by Application
  7. 5.2.1 Global Anti-Malarial Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-Malarial Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Anti-Malarial Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Anti-Malarial Drug Sales Value by Application
  11. 5.3.1 Global Anti-Malarial Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-Malarial Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Anti-Malarial Drug Sales Value Share by Application (2021-2032)
6 Anti-Malarial Drug Regional Sales and Value Analysis
  1. 6.1 Global Anti-Malarial Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Malarial Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Malarial Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-Malarial Drug Sales by Region (2027-2032)
  5. 6.3 Global Anti-Malarial Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-Malarial Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-Malarial Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-Malarial Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-Malarial Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-Malarial Drug Sales Value (2021-2032)
  12. 6.6.2 North America Anti-Malarial Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-Malarial Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-Malarial Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-Malarial Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-Malarial Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-Malarial Drug Sales Value (2021-2032)
  21. 6.9.2 South America Anti-Malarial Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-Malarial Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-Malarial Drug Sales Value Share by Country, 2025 VS 2032
7 Anti-Malarial Drug Country-level Sales and Value Analysis
  1. 7.1 Global Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Malarial Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-Malarial Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-Malarial Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-Malarial Drug Sales by Country (2027-2032)
  6. 7.4 Global Anti-Malarial Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-Malarial Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-Malarial Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-Malarial Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-Malarial Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-Malarial Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alvizia
  2. 8.1.1 Alvizia Company Information
  3. 8.1.2 Alvizia Business Overview
  4. 8.1.3 Alvizia Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alvizia Anti-Malarial Drug Product Portfolio
  6. 8.1.5 Alvizia Recent Developments
  7. 8.2 F. Hoffmann-La Roche
  8. 8.2.1 F. Hoffmann-La Roche Company Information
  9. 8.2.2 F. Hoffmann-La Roche Business Overview
  10. 8.2.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio
  12. 8.2.5 F. Hoffmann-La Roche Recent Developments
  13. 8.3 Ipca
  14. 8.3.1 Ipca Company Information
  15. 8.3.2 Ipca Business Overview
  16. 8.3.3 Ipca Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ipca Anti-Malarial Drug Product Portfolio
  18. 8.3.5 Ipca Recent Developments
  19. 8.4 Ranbaxy
  20. 8.4.1 Ranbaxy Company Information
  21. 8.4.2 Ranbaxy Business Overview
  22. 8.4.3 Ranbaxy Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ranbaxy Anti-Malarial Drug Product Portfolio
  24. 8.4.5 Ranbaxy Recent Developments
  25. 8.5 Zydus Cadila
  26. 8.5.1 Zydus Cadila Company Information
  27. 8.5.2 Zydus Cadila Business Overview
  28. 8.5.3 Zydus Cadila Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Cadila Anti-Malarial Drug Product Portfolio
  30. 8.5.5 Zydus Cadila Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Anti-Malarial Drug Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Anti-Malarial Drug Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Anti-Malarial Drug Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Anti-Malarial Drug Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Anti-Malarial Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Anti-Malarial Drug Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Malarial Drug Value Chain Analysis
  2. 9.1.1 Anti-Malarial Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Malarial Drug Sales Mode & Process
  6. 9.2 Anti-Malarial Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Malarial Drug Distributors
  9. 9.2.3 Anti-Malarial Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst